Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

Centre urges Andhra Pradesh to scale up healthcare services through PPP model, focusing on nuclear medicine, diagnostics, ...

GE HealthCare’s focus is on connecting equipment, software, and consumables into care pathways, and simplifying its operating ...

Centre urges Andhra Pradesh to enhance healthcare through PPP model, focusing on nuclear medicine, radiology, and cancer ...

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

Let’s Innovate Together!’ During my tenure as ASNC president, I will work tirelessly so we can innovate together as the ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

A small Canadian province feared it had a mystery neurological illness on its hands. The search for answers set off a battle ...

A small Canadian province feared it had a mystery neurological illness on its hands. The search for answers set off a battle ...

Bayer is successfully executing on an ambitious growth strategyFive pivotal approvals worldwide in 2025 underscore a landmark year of strategic executionBayer will drive significant global regulatory ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...